Cargando…
Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest
There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival dis...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738407/ https://www.ncbi.nlm.nih.gov/pubmed/29263333 http://dx.doi.org/10.1038/s41598-017-17686-3 |
_version_ | 1783287687848919040 |
---|---|
author | Niimura, Takahiro Zamami, Yoshito Koyama, Toshihiro Izawa-Ishizawa, Yuki Miyake, Masashi Koga, Tadashi Harada, Keisaku Ohshima, Ayako Imai, Toru Kondo, Yutaka Imanishi, Masaki Takechi, Kenshi Fukushima, Keijo Horinouchi, Yuya Ikeda, Yasumasa Fujino, Hiromichi Tsuchiya, Koichiro Tamaki, Toshiaki Hinotsu, Shiro Kano, Mitsunobu R. Ishizawa, Keisuke |
author_facet | Niimura, Takahiro Zamami, Yoshito Koyama, Toshihiro Izawa-Ishizawa, Yuki Miyake, Masashi Koga, Tadashi Harada, Keisaku Ohshima, Ayako Imai, Toru Kondo, Yutaka Imanishi, Masaki Takechi, Kenshi Fukushima, Keijo Horinouchi, Yuya Ikeda, Yasumasa Fujino, Hiromichi Tsuchiya, Koichiro Tamaki, Toshiaki Hinotsu, Shiro Kano, Mitsunobu R. Ishizawa, Keisuke |
author_sort | Niimura, Takahiro |
collection | PubMed |
description | There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use of hydrocortisone, using a Japanese health-insurance claims dataset that covers approximately 2% of the Japanese population. The study included the data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between January 2005 and May 2014. These patients were divided into two groups, based on the administration of hydrocortisone. We adjusted the baseline characteristics, medical treatment, and drug administration data of the two groups using propensity scores obtained via the inverse probability of treatment weighted method. The hydrocortisone group had a significantly higher survival discharge rate (13/61 [21.1%] vs. 240/2172 [11.0%], adjusted odds ratio: 4.2, 95% CI: 1.60–10.98, p = 0.004). In addition, the administration of hydrocortisone was independent predictor of survival to discharge (hazard ratio: 4.6, p < 0.001). The results demonstrate a correlation between hydrocortisone administration and the high rates of survival to discharge. |
format | Online Article Text |
id | pubmed-5738407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57384072017-12-22 Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest Niimura, Takahiro Zamami, Yoshito Koyama, Toshihiro Izawa-Ishizawa, Yuki Miyake, Masashi Koga, Tadashi Harada, Keisaku Ohshima, Ayako Imai, Toru Kondo, Yutaka Imanishi, Masaki Takechi, Kenshi Fukushima, Keijo Horinouchi, Yuya Ikeda, Yasumasa Fujino, Hiromichi Tsuchiya, Koichiro Tamaki, Toshiaki Hinotsu, Shiro Kano, Mitsunobu R. Ishizawa, Keisuke Sci Rep Article There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use of hydrocortisone, using a Japanese health-insurance claims dataset that covers approximately 2% of the Japanese population. The study included the data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between January 2005 and May 2014. These patients were divided into two groups, based on the administration of hydrocortisone. We adjusted the baseline characteristics, medical treatment, and drug administration data of the two groups using propensity scores obtained via the inverse probability of treatment weighted method. The hydrocortisone group had a significantly higher survival discharge rate (13/61 [21.1%] vs. 240/2172 [11.0%], adjusted odds ratio: 4.2, 95% CI: 1.60–10.98, p = 0.004). In addition, the administration of hydrocortisone was independent predictor of survival to discharge (hazard ratio: 4.6, p < 0.001). The results demonstrate a correlation between hydrocortisone administration and the high rates of survival to discharge. Nature Publishing Group UK 2017-12-20 /pmc/articles/PMC5738407/ /pubmed/29263333 http://dx.doi.org/10.1038/s41598-017-17686-3 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Niimura, Takahiro Zamami, Yoshito Koyama, Toshihiro Izawa-Ishizawa, Yuki Miyake, Masashi Koga, Tadashi Harada, Keisaku Ohshima, Ayako Imai, Toru Kondo, Yutaka Imanishi, Masaki Takechi, Kenshi Fukushima, Keijo Horinouchi, Yuya Ikeda, Yasumasa Fujino, Hiromichi Tsuchiya, Koichiro Tamaki, Toshiaki Hinotsu, Shiro Kano, Mitsunobu R. Ishizawa, Keisuke Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest |
title | Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest |
title_full | Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest |
title_fullStr | Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest |
title_full_unstemmed | Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest |
title_short | Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest |
title_sort | hydrocortisone administration was associated with improved survival in japanese patients with cardiac arrest |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738407/ https://www.ncbi.nlm.nih.gov/pubmed/29263333 http://dx.doi.org/10.1038/s41598-017-17686-3 |
work_keys_str_mv | AT niimuratakahiro hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT zamamiyoshito hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT koyamatoshihiro hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT izawaishizawayuki hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT miyakemasashi hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT kogatadashi hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT haradakeisaku hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT ohshimaayako hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT imaitoru hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT kondoyutaka hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT imanishimasaki hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT takechikenshi hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT fukushimakeijo hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT horinouchiyuya hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT ikedayasumasa hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT fujinohiromichi hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT tsuchiyakoichiro hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT tamakitoshiaki hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT hinotsushiro hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT kanomitsunobur hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest AT ishizawakeisuke hydrocortisoneadministrationwasassociatedwithimprovedsurvivalinjapanesepatientswithcardiacarrest |